(1)
In Vitro Biomimetic HPLC and in Vivo Characterisation of GM6, an Endogenous Regulator Peptide Drug Candidate for Amyotrophic Lateral Sclerosis. ADMET DMPK 2018, 6 (2), 176-189. https://doi.org/10.5599/admet.547.